|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-3-21
|
|
pubmed:abstractText |
To determine the efficacy of Ag85A-DNA against challenge with a highly virulent human clinical isolate of Mycobacterium tuberculosis (CSU37) and to compare the potencies of two types of Ag85A-DNA vaccines; those expressing secreted and non-secreted forms of the protein.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0962-8479
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
251-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10692994-Acyltransferases,
pubmed-meshheading:10692994-Animals,
pubmed-meshheading:10692994-Antigens, Bacterial,
pubmed-meshheading:10692994-BCG Vaccine,
pubmed-meshheading:10692994-Female,
pubmed-meshheading:10692994-Mice,
pubmed-meshheading:10692994-Mice, Inbred BALB C,
pubmed-meshheading:10692994-Mycobacterium tuberculosis,
pubmed-meshheading:10692994-Tuberculosis,
pubmed-meshheading:10692994-Vaccines, DNA
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
|
|
pubmed:affiliation |
Department of Microbiology, Colorado State University, Fort Collins 80523, USA. susanb@lamar.colostate.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
